Pharmaceuticals, Biotechnology and Life Sciences
MARLBOROUGH, Mass.–(BUSINESS WIRE)–Sunovion Pharmaceuticals Inc. (Sunovion) said Wednesday in a press release that it has withdrawn the New Drug Applications…
DUBLIN–(BUSINESS WIRE)–The “Global Attention-Deficit Hyperactivity Disorder (ADHD) Market: Size, Trends and Forecast (2019-2023)” report has been added to ResearchAndMarkets.com’s offering.…
Mylan has had a rather busy week, as it got approvals for three of its generic medicines in last three days. It announced launching three generics into the multi-billion U.S. worth market on Wednesday and Thursday.